59 /100
MEDIUM RISK
Score updated Feb 27, 2026
AVTX
Avalo Therapeutics, Inc.

DilutionScore™ measures dilution risk across 5 factors. Lower scores indicate higher risk of share dilution.

🔔 Get alerts when AVTX's score changes →
📊 Score Breakdown
📋 Offering Ability
80
💰 Cash Runway
60
📊 Float Risk
45
⚠️ Warrant Exposure
30
🔄Convertible Debt
💹 Market Data
Market Cap$326.56M
Shares Outstanding18.51M
Float10.86M
Cash$111.62M
Debt$555.0K
Short InterestN/A
🏛 Institutional Holdings
67 institutional holders · 15.62M shares
#1 BVF INC/IL 1.36M shares
#2 ORBIMED ADVISORS LLC 1.35M shares
#3 Nantahala Capital Management, LLC 1.24M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.98M
Days to Cover10.2
% of Float27.4%
FINRA data as of Jan 15, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Dec 31, 2024
xbrl XBRL WARRANT Dec 31, 2024
Full SEC filing analysis available with free account
📰 Recent News
Track AVTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AVTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required